patent_id,patent_date,patent_title,patent_num_times_cited_by_us_patents,cpc_subclass_ids
12428658,2025-09-30,Methods and compositions for enzymatic polymerization of N3′→P5′ phosphoramidate DNA,0,C07K|C12N|C12P|C12Q|C12Y
12428490,2025-09-30,Methods and compositions for chimeric antigen receptor targeting cancer cells,0,A61K|A61P|C07K|G01N
12427521,2025-09-30,Sorting particles in a microfluidic device,0,A61K|B01L|G01N
12421557,2025-09-23,Methods for predicting outcomes and treating colorectal cancer using a cell atlas,0,A61K|C12Q|G01N|Y02A
12419948,2025-09-23,Immunogenic compositions and use thereof,0,A61K|A61P|C12N|G01N
12419913,2025-09-23,Modification of CAR-T cells,0,A61K|A61P|C07K
12419885,2025-09-23,Kinase inhibitors and methods of use thereof,0,A61K|A61P|C07D
12409457,2025-09-09,Devices and method for enrichment and alteration of cells and other particles,0,B01L|B03C|B33Y|C12M|C12Q|G01N|Y10T
12409249,2025-09-09,Compositions and methods for immune tolerance,0,A61K|A61L|A61P|C12N|Y02A
12404525,2025-09-02,Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells,0,C07K|C12N
12404507,2025-09-02,Using micrornas to control activation status of hepatic stellate cells and to prevent fibrosis in progressive liver diseases,0,A61K|A61P|C12N
12398145,2025-08-26,Bicyclic urea kinase inhibitors and uses thereof,0,A61K|A61P|C07D
12396996,2025-08-26,"Compounds, pharmaceutical compositions, and methods of their use in reversing cancer chemoresistance",0,A61K|A61P|C07D
12385908,2025-08-12,Size-based particle separation and concentration using particle size amplification,0,B01L|G01N
12385041,2025-08-12,Conditional-siRNAS and uses thereof in treating cardiac hypertrophy,0,C12N|C12Q
12385033,2025-08-12,High-resolution spatial macromolecule abundance assessment,0,C12N|C12Q
12384834,2025-08-12,Anti-ApoE antibodies and polynucleotides thereof,0,A61K|A61P|C07K
12383528,2025-08-12,Cromolyn esters and uses thereof,0,A61K|A61P|C07B|C07D
12378510,2025-08-05,Lung bioreactor,0,A01N|A61K|C12M
12378297,2025-08-05,Chimeric antigen receptor T cells targeting the tumor microenvironment,0,A61K|A61P|C07K
12374435,2025-07-29,Methods for treating infections,0,C12Q|G16B|G16H
12371732,2025-07-29,Methods of preparing nucleic acids for sequencing,0,C12Q
12370210,2025-07-29,Carbon monoxide as a treatment for neurodegenerative disease,0,A61K|A61P
12366512,2025-07-22,Methods and systems for non-destructive estimation of scattering particle size,0,G01N
12357675,2025-07-15,Efficient protein expression in vivo using modified RNA (mod-RNA),0,A01K|A61K|A61L|A61P|C12N
12351815,2025-07-08,Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells,0,C07K|C12N
12351814,2025-07-08,Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells,0,C07K|C12N
12350290,2025-07-08,Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders,0,A61K|A61M|A61P|C07K|C12N|G01N
12343353,2025-07-01,Modulating phosphatase activity in cardiac cells,0,A01K|A61K|A61P|C07K|C12N
12331363,2025-06-17,Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers,0,C12Q
12331319,2025-06-17,Respiratory and sweat gland ionocytes,0,A61K|A61P|C12N|G01N
12319938,2025-06-03,Enhanced virus-like particles and methods of use thereof for delivery to cells,0,C07K|C12N
12313625,2025-05-27,"Living tissue model device, vascular wall model, vascular wall model device and method of evaluating test substance",0,G01N
12312613,2025-05-27,Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants,0,C07K|C12N|C12Y
12286641,2025-04-29,Methods for increasing efficiency of nuclease-induced homology-directed repair,0,C07K|C12N
12285502,2025-04-29,HER3 peptides for imaging and radiotherapy,0,A61K|A61P|C07K
12285446,2025-04-29,Compositions and methods for improving mitochondrial function,0,A23K|A23L|A23V|A61K|A61P|C07K|C12N|C12Y
12277866,2025-04-15,Organosynthetic dynamic heart model,0,A61F|A61L|B33Y|G01N|G09B
12276670,2025-04-15,Methods for identifying and treating adrenomyeloneuropathy (AMN),0,A61P|C07K|G01N
12269891,2025-04-08,Agonistic anti-tumor necrosis factor receptor 2 antibodies,0,A61K|A61P|C07K|G01N
12264341,2025-04-01,CRISPR-Cas enzymes with enhanced on-target activity,0,C07K|C12N
12251219,2025-03-18,"Systems, methods, and apparatus for differential phase contrast microscopy by transobjective differential epi-detection of forward scattered light",0,A61B|G01N|G02B
12246075,2025-03-11,Granzyme B directed imaging and therapy,0,A61B|A61K|A61P|C12Q
12241096,2025-03-04,Engineered CRISPR-Cas9 nucleases with altered PAM specificity,0,A61K|C07K|C12N
12239126,2025-03-04,Methods and compositions for preserving tissues and organs,0,A01N|G01N
12233107,2025-02-25,GHRH or analogues thereof for use in treatment of hepatic disease,0,A61K|A61P
12227578,2025-02-18,"Modulation of intestinal epithelial cell differentiation, maintenance and/or function through T cell action",0,A61K|A61P|C07K|C12N|G01N
12226520,2025-02-18,Self-fueled particles for propulsion through flowing aqueous fluids,0,A61K|A61L|A61P|C01F|C01P|C12Y
12226479,2025-02-18,Methods and compositions of use of CD8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof,0,A61K|A61P|C12N|C12Q|G01N
12226446,2025-02-18,WS-635 uses thereof in medicine,0,A61K|A61P
12220704,2025-02-11,Concentrating particles in a microfluidic device,0,A61K|B01L|G01N
12215382,2025-02-04,Liver protective MARC variants and uses thereof,0,A61K|C12Q
12209909,2025-01-28,Systems and methods for stimulated Brillouin microscopy,0,G01J|G01N|H01S
12208047,2025-01-28,Method and apparatus for dermatological treatment,0,A61B|A61H|A61K|A61L|A61Q
12208001,2025-01-28,Methods and systems for preventing or reducing stenosis in a subject receiving a graft,0,A01N|A61F|A61K|A61L|A61M|A61N
12207648,2025-01-28,"Vessel treatment systems, methods, and kits",0,A01N|A61F|A61M|A61P
12202861,2025-01-21,"Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1",0,A61K|C07K|C12N
12202856,2025-01-21,"Tethered interleukin-2 to its receptor IL-2RBETA, a platform to enhance natural killer and regulatory T cell activity",0,A61K|A61P|C07K|C12N
12195424,2025-01-14,Antibiotic compounds,0,A01N|A61K|A61P|C07C|Y02A
12193996,2025-01-14,Monocyte compositions and methods for the treatment of infectious disease,0,A61K|A61P
12188925,2025-01-07,"Multi-stage, multiplexed target isolation and processing from heterogeneous populations",0,B01L|G01N
12187722,2025-01-07,Small molecule inhibitors of TEAD transcription factors,0,A61K|A61P|C07C|C07D
12180520,2024-12-31,Engineered CRISPR-Cas9 nucleases with altered PAM specificity,0,A01K|A61K|C07K|C12N|C12Y
12180447,2024-12-31,Bone marrow microfluidic devices and methods for preparing and using the same,0,B01L|C12M|C12N|G01N
12178845,2024-12-31,Methods and compositions relating to the treatment of tumors,0,A01K|A61K|A61P|C07K|C12N
12174188,2024-12-24,Methods of identifying subjects responsive to treatment for type 1 diabetes and compositions for treating the same,0,A61K|A61P|G01N
12174115,2024-12-24,Resolving absolute depth in circular-ranging optical coherence tomography,0,G01B|G01N
12173339,2024-12-24,Variants of Cpf1 (Cas12a) with altered PAM specificity,0,C12N|C12Q|C12Y|Y02A
12171783,2024-12-24,Methods and compositions for targeting developmental and oncogenic programs in H3K27M gliomas,0,A61K|A61P|C07K
12171773,2024-12-24,Inhibiting inflammation with milk oligosaccharides,0,A23L|A61K|A61P
12161668,2024-12-10,T cells expressing a chimeric antigen receptor,0,A61K|A61P|C07K
12157888,2024-12-03,Modulating the cellular stress response,0,A61P|C12N
12157885,2024-12-03,Methods of screening using barcoded libraries,0,A61K|C12N|C12Q|C40B
12152254,2024-11-26,TAL-Tet1 fusion proteins and methods of use thereof,0,A61P|C07K|C12N
12152241,2024-11-26,Targeting human satellite II (HSATII),0,A61K|A61P|C12N|C12Q
12152082,2024-11-26,Antagonistic anti-tumor necrosis factor receptor superfamily antibodies,0,A61K|A61P|C07K
12152080,2024-11-26,Compositions and methods for non-myeloablative conditioning,0,A61K|A61P|C07K|G01N
12138321,2024-11-12,Half-curcuminoids as amyloid-β PET imaging agents,0,A61K|A61P|C07B|C07C|C07F
12134721,2024-11-05,Complexes and ligands,0,C07C|C07D|C07F|C09K|G01N
12129287,2024-10-29,Recombinant adeno associated virus encoding clarin-1 and uses thereof,0,A61K|A61P|C07K|C12N
12121534,2024-10-22,Agents and methods for treating pancreatic ductal adenocarcinomas,0,A61K|C12N|C12Q|G01N
12121521,2024-10-22,Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis,0,A61K|A61P
12115289,2024-10-15,Drug eluting polymer composed of biodegradable polymers applied to surface of medical device,0,A61K|A61L|C08F|C08G|C08L
12115281,2024-10-15,Systems for and methods for using biomimetic structures providing communication in living tissue,0,A61F|A61L|C12M|C12N
12109301,2024-10-08,"Formulations, methods, and systems for treating genitourinary conditions",0,A61K|A61P
12105089,2024-10-01,Cell atlas of the healthy and ulcerative colitis human colon,1,A61K|A61P|C12Q|G01N
12104207,2024-10-01,Genomewide unbiased identification of DSBs evaluated by sequencing (GUIDE-Seq),0,C12Q
12102695,2024-10-01,Half-curcuminoids as amyloid-beta pet imaging agents,0,A61K|A61P|C07B|C07C|C07F
12098178,2024-09-24,Methods of using interleukin-2 agents,0,A61K|A61P|C07K
12097282,2024-09-24,Injectable slurries and methods of manufacturing the same,0,A61K|A61P|A61Q
12092631,2024-09-17,Optical thromboelastography systems and methods,0,B01L|G01N
12078588,2024-09-03,Integrated multiplexed photometric module and method,0,B01L|G01N
12065668,2024-08-20,RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci,0,C07K|C12N|C12Y
12065648,2024-08-20,Methods and compositions for inhibiting detoxification response,0,A61K|A61P|C07K|C12N|G01N
12064408,2024-08-20,Compounds for the treatment of obesity and methods of use thereof,0,A61K|A61P
12059565,2024-08-13,Methods and systems for modulating unconsciousness or anesthesia in a subject,0,A61K|A61N
12059481,2024-08-13,"Compounds, systems, and methods for monitoring and treating a surface of a subject",0,A61B|A61F|A61K|C07D
12054724,2024-08-06,AAV vectors encoding clarin-1 or GJB2 and uses thereof,0,A61K|A61P|C07K|C12N
12053774,2024-08-06,Modular instrumentation for analyzing biological fluids,0,B01L|G01N
12053470,2024-08-06,Pharmaceutical combination comprising an ALK inhibitor and a SHP2 inhibitor,0,A61K|A61P
12049482,2024-07-30,Molecular switch-mediated control of engineered cells,0,A61K|C07K|C12N
12048721,2024-07-30,Compositions of microbiota and methods related thereto,0,A61K|A61P|C12Q|Y02A
12018080,2024-06-25,Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway,0,A61K|A61P|C07K|C12N|Y02A
12006555,2024-06-11,Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments,0,A61P|C12Q|G01N
11999775,2024-06-04,VEGF-binding protein for blockade of angiogenesis,0,A61K|A61P|C07K|C12N
11998590,2024-06-04,Use of Mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation,0,A61K|A61P|C12N
11998540,2024-06-04,Compositions and methods for treating drug-tolerant glioblastoma,0,A61K|A61P
11987807,2024-05-21,Isolated human lung progenitor cells and uses thereof,0,A61K|A61L|A61P|C12N|G01N|G03B
11987795,2024-05-21,Methods of modulating SLC7A11 pre-mRNA transcripts for diseases and conditions associated with expression of SLC7A11,0,A61K|C12N
11986266,2024-05-21,Speckle-based image distortion correction for laser scanning microscopy,0,A61B|G01N|G02B
11982671,2024-05-14,Identification of a T cell epitope of Prevotella copri that induces T cell responses in patients with rheumatoid arthritis,0,C07K|G01N
11976324,2024-05-07,"Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents",0,C12N|C12Q|C12Y
11975050,2024-05-07,Parathyroid hormone polypeptide conjugates and methods of their use,0,A61K|C07K
11971406,2024-04-30,Capture and release of particles from liquid samples,0,G01N
11964017,2024-04-23,Compositions and methods for treatment of neurological disorders,0,A61B|A61F|A61K|A61P
11958887,2024-04-16,Gene therapy for tuberous sclerosis,0,A01K|A61K|A61P|C07K|C12N
11946040,2024-04-02,Adenine DNA base editor variants with reduced off-target RNA editing,0,C12N|C12Y
11944972,2024-04-02,Concentrating particles in a microfluidic device,1,A61K|B01L|G01N
11944971,2024-04-02,Sorting particles in a microfluidic device,2,A61K|B01L|G01N
11939637,2024-03-26,Molecular biomarkers for cancer immunotherapy,0,C12Q|G01N
11939571,2024-03-26,Library-scale engineering of metabolic pathways,0,C12N|C40B
11939369,2024-03-26,Integrin antagonists,0,A61K|C07K
11938188,2024-03-26,Injectable slurries and methods of manufacturing and using the same,0,A61B|A61F|A61K|A61P
11938129,2024-03-26,Methods and compositions for the treatment of vascular disease,0,A61K|A61P|C12N|C12Q
11926849,2024-03-12,Biosensors in human gut organoids,0,C12N|G01N
11921109,2024-03-05,Microfluidic system and method for real-time measurement of antibody-antigen binding and analyte detection,0,B01F|B01L|G01N
11920152,2024-03-05,Increasing specificity for RNA-guided genome editing,4,C07K|C12N|C12Y
11912994,2024-02-27,Methods for reactivating genes on the inactive X chromosome,0,C12N|C12Q|C12Y
11899022,2024-02-13,Multiplexed proteomics and predictive drug candidate assessment,0,G01N|G16B|H01J
11898209,2024-02-13,Digital analysis of circulating tumor cells in blood samples,1,C12Q
11898203,2024-02-13,"Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents",0,C12N|C12Q|C12Y
11891631,2024-02-06,Transcription activator-like effector (tale) - lysine-specific demethylase 1 (LSD1) fusion proteins,0,A61K|C07K|C12N|C12Y
11891593,2024-02-06,Lung bioreactor,0,A01N|A61K|C12M
11890356,2024-02-06,HDAC6 inhibitors and imaging agents,0,A61K|A61P|C07B|C07C|C07D|G01N
11890348,2024-02-06,Localized delivery of anti-fugetactic agent for treatment of cancer,0,A61K|A61P|C07K
11885733,2024-01-30,White blood cell population dynamics,0,G01N|G16Z
11883680,2024-01-30,Method and apparatus for tightening skin and other tissues,0,A61B|A61K|A61N
11878063,2024-01-23,Engineered ligands and uses thereof,0,A61K
11878019,2024-01-23,Uses of pyrimidopyrimidinones as SIK inhibitors,0,A61K|A61P
11866783,2024-01-09,Extracellular mRNA markers of muscular dystrophies in human urine,0,C12Q|G01N
11866736,2024-01-09,Protein prostheses for mitochondrial diseases or conditions,0,A61K|A61P|C07K|C12N|C12Y
11859220,2024-01-02,Engineered CRISPR-Cas9 nucleases with altered PAM specificity,0,A01K|A61K|C07K|C12N|C12Y
11859002,2024-01-02,Antagonistic anti-tumor necrosis factor receptor 2 antibodies,2,A61K|A61P|C07K|Y02A
11850216,2023-12-26,18F labeling of proteins using sortases,0,A61K|C07H|C07K|C12N|C12Y|G01N
11845987,2023-12-19,Highly sensitive in vitro assays to define substrate preferences and sites of nucleic acid cleaving agents,0,C12N|C12Q|C12Y
11845920,2023-12-19,Bone marrow microfluidic devices and methods for preparing and using the same,0,B01L|C12M|C12N|G01N
11844814,2023-12-19,Methods for expansion or depletion of T-regulatory cells,2,A61K|A61P|C07K|C12N|Y02A
11834718,2023-12-05,"Compositions and methods for diagnosing, evaluating and treating cancer by means of the DNA methylation status",0,C12Q|G16B
11826427,2023-11-28,Compositions and methods for treatment of neurological disorders,4,A61B|A61F|A61K|A61P
11819578,2023-11-21,Nanofiber scaffolds,0,A61K
11814687,2023-11-14,Methods for characterizing bladder cancer,0,C12Q
11813218,2023-11-14,Method and apparatus for dermatological treatment,0,A61B|A61H|A61K|A61L|A61Q
11807897,2023-11-07,Methods of preparing nucleic acids for sequencing,0,C12Q
11806372,2023-11-07,Methods of treating and diagnosing IBD associated with r. gnavus and/or r. gnavus group IBD colonization,0,A61K|A61P
11801374,2023-10-31,Methods and systems for non-contact construction of an internal structure,0,A61B|A61K|A61M|A61N
11801316,2023-10-31,Cromolyn derivatives and related methods of imaging and treatment,1,A61K|A61P|C07D
11795491,2023-10-24,Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same,0,A61P|C07D|C12Q|G01N
11788144,2023-10-17,Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease,0,C12Q|G01N
11788089,2023-10-17,Compositions and methods for modulating MECP2 expression,0,A61K|A61P|C07H|C12N
11787797,2023-10-17,"4,5-annulated 1,2,4-triazolones",0,A61K|A61P|C07D|C12N|C12P|Y02A
11781187,2023-10-10,Rare cell analysis using sample splitting and DNA tags,0,B01L|C12Q|G01N|Y10T
11781179,2023-10-10,Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence,0,A61P|C12Q
11780901,2023-10-10,Analogues of parathyroid hormone (1-34) that function as agonists of the parathyroid hormone receptor-1 and display modified activity profiles,0,A61K|C07K
11779661,2023-10-10,Theranostic nucleic acid binding fluorescent nanoprobes and uses thereof,0,A61K|C07D
11766446,2023-09-26,Treatment of aging-associated conditions by DNA degradation,0,A61K|A61P|C12N|C12Y
11766176,2023-09-26,"Apparatus, devices and methods for obtaining omnidirectional viewing by a catheter",0,A61B|G01N|G02B
11752238,2023-09-12,Recapitulating the hematopoietic niche to reconstitute immunity,1,A61L|A61P|C12N
11738066,2023-08-29,GHRH or analogues thereof for use in treatment of hepatic disease,1,A61K|A61P
11738056,2023-08-29,Compositions and methods for improving mitochondrial function,1,A23K|A23L|A23V|A61K|A61P|C07K|C12N|C12Y
11732257,2023-08-22,"Single cell sequencing libraries of genomic transcript regions of interest in proximity to barcodes, and genotyping of said libraries",0,C12N|C12Q|C40B|G01N
11730758,2023-08-22,Compositions and methods comprising energy absorbing materials for follicular delivery,0,A61K|A61P
11730430,2023-08-22,System and method for single-scan rest-stress cardiac pet,1,A61B|A61K
11725237,2023-08-15,Polymorphic gene typing and somatic change detection using sequencing data,0,C12Q|G16B
11725228,2023-08-15,Methods for detecting site-specific and spurious genomic deamination induced by base editing technologies,1,C07K|C12N|C12Q
11725180,2023-08-15,Microfluidic sorting using high gradient magnetic fields,0,B01L|B03C|C12M|G01N
11725061,2023-08-15,CSGP4—specific chimeric antigen receptor for cancer,0,A61K|A61P|C07K
11725011,2023-08-15,Bicyclic urea kinase inhibitors and uses thereof,2,A61K|A61P|C07D
11723950,2023-08-15,CAL-T constructs and uses thereof,0,A61K|A61P|C07K|C12N|Y02A
11723589,2023-08-15,"Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine",0,A61B|A61K|A61P
11719711,2023-08-08,Compositions and methods for detecting and/or treating inflammation,0,A61K|A61P|C07K|G01N
11718683,2023-08-08,Antigen-binding fusion proteins with modified HSP70 domains,0,A61K|A61P|C07K
11713304,2023-08-01,"2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH",0,A61K|A61P|C07D|Y02A
11708353,2023-07-25,Inhibitors of prolyl-tRNA-synthetase,0,A61P|C07D
11707442,2023-07-25,Antibacterial and antifungal compounds,0,A61K|A61P|Y02A
11702417,2023-07-18,Compounds for improving mRNA splicing,0,A61P|C07D
11701437,2023-07-18,Systemic delivery of polypeptides,0,A61K|A61N|C12N
11690902,2023-07-04,Coxiella burnetii epitopes for T cell-targeted Q fever vaccines,0,A61K|C07K
11690824,2023-07-04,Antibacterial compounds,0,A61K|A61P|C07D
11690540,2023-07-04,"Systems, methods, and apparatus for differential phase contrast microscopy by transobjective differential EPI-detection of forward scattered light",1,A61B|G01N|G02B
11685717,2023-06-27,Polypeptide integrin antagonists,0,A61K|A61P|C07B|C07D|C07K
11684419,2023-06-27,Systems and methods for selective targeting of structural features in treating skin conditions,0,A61B|A61K
11684388,2023-06-27,Method and apparatus for grafting of skin tissue,0,A61B|A61F|A61P
11679095,2023-06-20,Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases,1,A61K|A61P|C07D
11674176,2023-06-13,Fetal aneuploidy detection by sequencing,0,C12Q
11674125,2023-06-13,Glycoengineering,0,A61K|A61P|C07K|C12N|C12Y
11673855,2023-06-13,Voltage gated sodium channel imaging agents,0,A61K|C07B|C07C
11667677,2023-06-06,"Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1",2,A61K|C07K|C12N
11666669,2023-06-06,Cromolyn derivatives and related methods of imaging and treatment,2,A61K|A61P|C07D
11666664,2023-06-06,Self assembling molecules for targeted drug delivery,0,A61K|A61P
11661586,2023-05-30,Extracellular redox enzyme system to alleviate disease,0,A61K|A61P|C07K|C12N|C12Y
11655210,2023-05-23,Compound for improving L-arginine bioavailability,0,A61K|C07C
11644409,2023-05-09,Integrated multiplexed photometric module and method,0,B01L|G01N
11643393,2023-05-09,Integrin antagonists,0,A61K|A61P|C07B|C07D|C07K
11639325,2023-05-02,Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders,0,A61K|A61P|C07C
11635379,2023-04-25,Portable wide field fluorimeter systems,1,B01L|C12Q|C12Y|G01N
11634777,2023-04-25,Resistance to checkpoint blockade therapy,0,A61K|C07K|C12Q
11634731,2023-04-25,Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing,6,C07K|C12N|C12Y
11634448,2023-04-25,Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions,0,A61K|A61L|C07H|C12N
11633436,2023-04-25,Cholesterol reducing compositions and methods of use thereof,0,A23L|A61K|A61P|C12N|C12Q|C12Y|C40B|G01N|Y02A
11630103,2023-04-18,Product and methods useful for modulating and evaluating immune responses,0,A61K|C12N|G01N
11624058,2023-04-11,Engineered CRISPR-Cas9 nucleases with altered PAM specificity,0,A61K|C07K|C12N
11623041,2023-04-11,Flow rate measurement and control of infusion devices,0,A61M|G01F|G01G|G01N|G16H
11613574,2023-03-28,Methods and compositions relating to ex vivo culture and modulation of T cells,0,A61K|A61P|C07K|C12N
11608533,2023-03-21,Compositions and methods for classifying tumors with microsatellite instability,0,C12Q|G16B
11597934,2023-03-07,Methods and compositions for reducing immunosuppression by tumor cells,2,A61K|A61P|C07K|C12N|C12Q
11596691,2023-03-07,Photoswitchable HDAC inhibitors,0,A61K|A61P|C07C|C07D|C07F
11591589,2023-02-28,Variants of Cpf1 (Cas12a) with altered PAM specificity,1,C12N|C12Q|C12Y|Y02A
11590247,2023-02-28,System and method for electrical control of bacteria,0,A61B|A61L|A61M|A61N|C12N
11590176,2023-02-28,Compositions of microbiota and methods related thereto,2,A61K|A61P|C12Q|Y02A
11579088,2023-02-14,Device and method for imaging shortwave infrared fluorescence,0,A61B|G01N
11578115,2023-02-14,Chimeric antigen receptors based on alternative signal 1 domains,0,A61K|A61P|C07K|C12N
11576571,2023-02-14,Systems and methods for Brillouin spectroscopy and imaging of tissues,0,A61B|A61F|G01J|G01N|G02B|H01S
11572368,2023-02-07,Inhibitors of histone deacetylase,1,A61K|A61P|C07C|C07D
11571427,2023-02-07,Targeting the CBM signalosome complex induces regulatory T cells to inflame the tumor microenvironment,0,A61K|A61P|C07K|C12Q
11564942,2023-01-31,Methods for generating universal and custom MHC/HLA-compatible hematopoietic progenitor cells,0,A61K|C07K|C12N
11559590,2023-01-24,Granzyme B directed imaging and therapy,1,A61B|A61K|A61P|C12Q
11555031,2023-01-17,Compounds and methods for regulating insulin secretion,0,A61P|C07C|C07D
11553876,2023-01-17,"Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine",0,A61B|A61K|A61P
11553841,2023-01-17,"Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions",0,A61B|G01B|G01N
11548002,2023-01-10,Engineered nano-interfaces for microfluidic isolation of extracellular vesicles,0,B01F|B01L|G01N
11547694,2023-01-10,CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated disease,0,A61K|A61P|C07K|C12N
11547300,2023-01-10,Methods of treating and imaging tumor micrometastases using photoactive immunoconjugates,0,A61B|A61K|A61P|G01J|G06T
11534530,2022-12-27,Systems for and methods for using biomimetic structures providing communication in living tissue,0,A61F|A61L|C12M|C12N
11525778,2022-12-13,Portable diffraction-based imaging and diagnostic systems and methods,0,C12Q|G01N|G03H
11523985,2022-12-13,"Formulations, methods, and systems for treating genitourinary conditions",0,A61K|A61P
11519036,2022-12-06,Use of microvesicles in analyzing nucleic acid profiles,0,C12Q|G01N
11518793,2022-12-06,"Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation",0,A61K|C07K|C12N
11510983,2022-11-29,Method and apparatus for boosting vaccine efficacy,0,A61B|A61K|A61M|A61N|C12N|Y02A
11504389,2022-11-22,Tau modulators and methods and compositions for delivery thereof,1,A61K|A61P|C07K|C12N
11504322,2022-11-22,Injectable slurries and methods of manufacturing the same,6,A61K|A61P|A61Q
11498958,2022-11-15,Methods of diagnosis and treatment of tuberculosis and infection,0,A61K|C07K|Y02A
11498071,2022-11-15,Systems and methods for particle focusing in microchannels,0,B01D|B01L|B33Y|C12M|F16L|F17D|G01N|Y10T
11485781,2022-11-01,Multiple specificity binders of CXC chemokines,0,A61K|A61P|C07K
11484521,2022-11-01,Antidotes to cyanide poisoning,0,A61K|A61P
11479805,2022-10-25,Combinatorial single molecule analysis of chromatin,0,C12Q|G01N
11474023,2022-10-18,Oscillatory focusing of particles in channels,0,B01L|G01N
11473897,2022-10-18,Method and apparatus for measuring depth-resolved tissue birefringence using single input state polarization sensitive optical coherence tomography,1,G01B|G01N|G02B
11472849,2022-10-18,Methods of transcription activator like effector assembly,0,C07K|C12N|C12P|C12Q|C12Y|C40B
11471401,2022-10-18,Injectable slurries and methods of manufacturing the same,4,A61K|A61P|A61Q
11466093,2022-10-11,Antibody derivatives with conditionally enabled effector function,0,C07K
11460465,2022-10-04,Cell chemotaxis assays,0,B01L|C12M|G01N
11459570,2022-10-04,Transgenic mouse expressing amyloid precursor protein that has olfactory neuron degeneration,0,A01K|A61K|C07K|C12N
11453706,2022-09-27,HSP fusion protein with anti-chemorepellant agent for treatment of infectious disease,0,A61K|A61P|C07K
11452768,2022-09-27,Combination therapy with neoantigen vaccine,4,A61K|A61P|C07K
11446664,2022-09-20,Combined sorting and concentrating particles in a microfluidic device,0,A61K|B01L|G01N
11441196,2022-09-13,Ribosomal ribonucleic acid hybridization for organism identification,0,C12Q
11435368,2022-09-06,Biomarker for senescence and anti-senescence and use thereof,0,G01N
11434203,2022-09-06,8-hydroxyquinoline derivatives as diagnostic and therapeutic agents,0,A61K|A61P|C07B|C07D
11433136,2022-09-06,"Polyacetal polymers, conjugates, particles and uses thereof",0,A61K|A61P|C08G
11433068,2022-09-06,Treatment of cancers having alterations within the SWI/SNF chromatin remodeling complex,0,A61K|A61P|C12Q
11427797,2022-08-30,Lung bioreactor,0,A01N|A61K|C12M
11427543,2022-08-30,Compounds for targeting cancer stem cells,0,A61K|A61P|C07C|C07D
11426450,2022-08-30,Shear-thinning compositions as an intravascular embolic agent,2,A61K|A61L|A61P
11421233,2022-08-23,Methods relating to circulating tumor cell clusters and the treatment of cancer,0,A61P|C12N|C12Q
11419894,2022-08-23,Modified natural killer cells for the treatment of cancer,0,A61K|A61P|C07K
11413092,2022-08-16,Systems and methods to facilitate delivery of a therapeutic agent into the skin of a subject,0,A61B|A61K|A61M
11401518,2022-08-02,Methods of reducing expression of x-inactivation escapee genes and autosomal genes,0,A61K|C12N
11400310,2022-08-02,Method and apparatus for tightening skin and other tissues,0,A61B|A61K|A61N
11400183,2022-08-02,Three dimensional microtissue bioprinter,1,A61L|B01L|B29C|B33Y|B41J|C12M|C12N|G01N
11400171,2022-08-02,Manganese-based chelate conjugates for molecular MR imaging,0,A61K|C07D|C07F|C07K|G16H
11396516,2022-07-26,Tricyclic compounds as Cyp1 inhibitors,0,A61K|A61P|C07D
11382908,2022-07-12,Compositions and methods for treating inflammatory bowel disease,0,A61K|A61P
11382883,2022-07-12,Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections,0,A01N|A61K|A61P|Y02A
11378498,2022-07-05,Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats,0,C12Q|G01N|G16B
11377423,2022-07-05,Inhibitors of histone deacetylase,2,A61K|A61P|C07C|C07D
11371101,2022-06-28,Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers,1,C12Q
11364264,2022-06-21,Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer,0,A61K|A61P|C07K|C12N
11352434,2022-06-07,Chimeric antigen receptors targeting CD37,1,A61K|A61P|C07K
11352326,2022-06-07,Myeloperoxidase imaging agents,0,A61K|C07D
11351144,2022-06-07,Compounds for inhibiting secretory leukocyte protease inhibitor (SLPI),0,A61K|A61P
11350625,2022-06-07,"Vessel treatment systems, methods, and kits",0,A01N|A61F|A61M|A61P
11339442,2022-05-24,"Methods of detecting insulator dysfunction and oncogene activation for screening, diagnosis and treatment of patients in need thereof",1,C12Q
11337792,2022-05-24,Methods for tissue passivation,0,A01N|A61F|A61K|A61L|A61M|A61N
11332513,2022-05-17,Chimeric antigen receptors having GITR intracellular domain as co-stimulatory domain,0,C07K|C12N
11326157,2022-05-10,Base editors with improved precision and specificity,0,C07K|C12N|C12Y
11325951,2022-05-10,HSP fusion protein with anti-chemorepellant agent for treatment of cancer,0,A61K|A61P|C07K
11324765,2022-05-10,Inhibiting inflammation with milk oligosaccharides,0,A23L|A61K|A61P
11319571,2022-05-03,Red blood cell dynamics for gastrointestinal evaluation,0,A61P|C12Q|G01N
11319357,2022-05-03,"Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy",0,A61B|C07K|G01B|G01J|G01N|G02B
11305017,2022-04-19,Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer,0,A61K|A61P|C07K
11293852,2022-04-05,White blood cell population dynamics,1,G01N|G16Z
11291678,2022-04-05,Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin,0,A61K|A61P
11291648,2022-04-05,Powdered formulations of cromolyn sodium and alpha-lactose,3,A61K
11289879,2022-03-29,System and method for micro laser particles,0,G01J|G01N|G02B|H01S
11286468,2022-03-29,Engineered CRISPR-Cas9 nucleases with altered PAM specificity,2,A61K|C07K|C12N
11285158,2022-03-29,Uses of pyrimidopyrimidinones as SIK inhibitors,0,A61K|A61P
11285144,2022-03-29,Use of CDK8 inhibitors to treat diseases of inflammation and autoimmunity,1,A61K|G01N|Y02A
11279765,2022-03-22,Compositions and methods to improve anti-angiogenic therapy and immunotherapy,0,A61K|A61P|C07K|C12N|G01N
11278025,2022-03-22,Antibiotic compounds,0,A01N|A61K|A61P|C07C|Y02A
11275018,2022-03-15,Integrated multiplexed photometric module and method,1,B01L|G01N
11266730,2022-03-08,Methods of treating and diagnosing disease using biomarkers for BCG therapy,2,A61K|A61P|C12Q|G01N
11266596,2022-03-08,Self-fueled particles for propulsion through flowing aqueous fluids,0,A61K|A61L|A61P|C01F|C01P|C12Y
11262361,2022-03-01,Selective capture and release of rare mammalian cells using photodegradable hydrogels in a microfluidic platform,0,A61K|B01L|C08F|C12M|G01N
11261492,2022-03-01,Methods for the diagnosis of fetal abnormalities,0,C12Q|G01N
11253613,2022-02-22,"Compounds, systems, and methods for monitoring and treating a surface of a subject",0,A61B|A61F|A61K|C07D
11241511,2022-02-08,HER3 peptides for imaging and radiotherapy,1,A61K|A61P|C07K
11241435,2022-02-08,Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis,1,A61K|A61P
11236336,2022-02-01,Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy,0,A61K|A61P|C12N
11229726,2022-01-25,Biodegradable silk ear tubes,0,A61F|A61L|A61M|A61P
11224378,2022-01-18,Therapeutic laser system and method,0,A61B|A61K|A61M
11220678,2022-01-11,Engineered CRISPR-Cas9 nucleases with altered PAM specificity,1,A01K|A61K|C07K|C12N|C12Y
11214769,2022-01-04,Isolated human lung progenitor cells and uses thereof,0,A61K|A61L|A61P|C12N|G01N|G03B
11213534,2022-01-04,Modulating phosphatase activity in cardiac cells,0,A01K|A61K|A61P|C07K|C12N
11207431,2021-12-28,HDAC6 inhibitors and imaging agents,1,A61K|A61P|C07B|C07C|C07D|G01N
11197467,2021-12-14,"Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes",0,A01K|A61K|C07K|C12N
11180438,2021-11-23,Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders,0,A61K|A61P|C07C
11172888,2021-11-16,Optical blood-coagulation sensor,0,A61B|G01N
11172827,2021-11-16,Apparatus and method for providing mesoscopic spectroscopy co-registered with optical frequency domain imaging,0,A61B|G01B|G01J|G01N
11168369,2021-11-09,Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease,1,C12Q|G01N
11168338,2021-11-09,RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci,16,C07K|C12N|C12Y
11168313,2021-11-09,Variants of CRISPR from Prevotella and Francisella 1 (Cpf1),2,C07K|C12N|C12Y|Y02A
11167066,2021-11-09,Local drug delivery devices and methods for treating cancer,0,A61F|A61K|A61L|A61P
11162895,2021-11-02,Systems and methods for characterizing biological material using near-infrared spectroscopy,0,G01N
11155874,2021-10-26,Use of microvesicles in analyzing mutations,0,C12Q
11155779,2021-10-26,Microfluidic sorting with high gradient magnetic fields using opposing arrays of adjacent magnets,1,B01L|B03C|C12M|G01N
11154559,2021-10-26,Methods and compositions of bile acids,0,A61K|A61P
11150173,2021-10-19,Laser speckle micro-rheology in characterization of biomechanical properties of tissues,0,G01N
11142800,2021-10-12,Biomarkers of cancer,0,C12Q
11136553,2021-10-05,"Isolated adult cells, artificial organs, rehabilitated organs, research tools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same",0,A01N|A61K|A61M|C12N
11136291,2021-10-05,Antifungal compounds and uses thereof,0,A61P|C07C|C07D
11135445,2021-10-05,Antimicrobial photodynamic inactivation procedure and system,0,A61B|A61K|A61N|G02B
11135318,2021-10-05,Half-curcuminoids as amyloid-beta PET imaging agents,0,A61K|A61P|C07B|C07C|C07F
11135269,2021-10-05,Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation,1,A61K|A61P|C12N
11130951,2021-09-28,Modulating the cellular stress response,0,A61P|C12N
11130745,2021-09-28,"2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH",2,A61K|A61P|C07D|Y02A
11130132,2021-09-28,Microfluidic neutrophil assays and systems for disease detection,0,B01L|G01N
11129535,2021-09-28,"Apparatus, devices and methods for obtaining omnidirectional viewing by a catheter",0,A61B|G01N|G02B
11125745,2021-09-21,Magnetic electrochemical sensing,1,G01N
11123047,2021-09-21,Hybrid systems and methods for multi-modal acquisition of intravascular imaging data and counteracting the effects of signal absorption in blood,36,A61B|G01N
11117884,2021-09-14,Potent gamma-secretase modulators,0,A61P|C07D
11117858,2021-09-14,Voltage gated sodium channel imaging agents,1,A61K|C07B|C07C
11116819,2021-09-14,Methods and compositions for mobilizing stem cells,0,A61K|A61P|C12N|G01N
11111284,2021-09-07,Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing,3,A61K|A61P|C07K
11110097,2021-09-07,Combination therapies for the treatment of alzheimer's disease and related disorders,5,A61K|A61P|C07K
11109819,2021-09-07,System and method for quantitatively mapping mitochondrial membrane potential,0,A61B|A61K|G01N|G01R|G16H
11104937,2021-08-31,CRISPR effector system based diagnostics,23,C12N|C12Q
11098326,2021-08-24,Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing,16,C07K|C12N|C12Y
11098017,2021-08-24,Compounds for treating disorders associated with abnormal steroidogenesis,0,A61P|C07D
11096934,2021-08-24,Compounds and methods useful for treating or preventing hematological cancers,0,A61K|A61P
11091547,2021-08-17,Anti-chondroitin sulfate proteoglycan 4 antibodies and uses thereof,3,A61K|A61P|C07K
11084860,2021-08-10,Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases,0,A61K|A61P|C07K|Y02A
11084803,2021-08-10,Activators of class I histone deacetylases (HDACs) and uses thereof,0,A61P|C07C|C07D
11083780,2021-08-10,Shear-thinning compositions as an intravascular embolic agent,2,A61K|A61L|A61P
11079383,2021-08-03,Diagnosis and monitoring treatment of prostate cancer,0,A61K|C12Q|G01N
11066673,2021-07-20,Polycomb-associated non-coding RNAs,0,A61K|A61P|C12N|C12Q|C12Y
11060078,2021-07-13,Engineered CRISPR-Cas9 nucleases,1,C07K|C12N|C12Y
11058697,2021-07-13,Inhibiting inflammation with milk oligosaccharides,1,A23L|A61K|A61P
11052393,2021-07-06,Concentrating particles in a microfluidic device,4,A61K|B01L|G01N
11052392,2021-07-06,Microfluidic device for cell separation and uses thereof,0,B01L|B33Y|B82Y|C12N|G01N|Y10T
11052080,2021-07-06,Kinase inhibitors and methods of use thereof,1,A61K|A61P|C07D
11047003,2021-06-29,Systems and methods for epigenetic sequencing,1,B01F|B01L|C12Q
11045520,2021-06-29,Compositions and methods for topical delivery of pharmaceutical agents,0,A61K|A61Q
11045465,2021-06-29,Methods and compositions to prevent addiction,0,A61K|A61P
11045439,2021-06-29,Compounds for the treatment of obesity and methods of use thereof,0,A61K|A61P
11041204,2021-06-22,"FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases",0,A61P|C12N|C12Q|G01N
11041155,2021-06-22,CCCTC-binding factor variants,0,A61K|C07K|C12N
11034992,2021-06-15,Assays and methods for detecting UDP-glucose,0,C12Q|G01N
11029313,2021-06-08,Method of treating cervical neoplasia in patients infected with human papilloma virus,0,G01N
11028429,2021-06-08,Full interrogation of nuclease DSBs and sequencing (FIND-seq),1,C12N|C12Q|C40B
11027280,2021-06-08,Sorting particles in a microfluidic device,3,A61K|B01L|G01N
11021718,2021-06-01,Methods for increasing efficiency of nuclease-induced homology-directed repair,0,C07K|C12N
11015196,2021-05-25,Using microRNAs to control activation status of hepatic stellate cells and to prevent fibrosis in progressive liver diseases,1,A61K|A61P|C12N
11013686,2021-05-25,Cromolyn compositions and methods thereof,5,A61K|A61M|A61P
11009508,2021-05-18,Methods of diagnosing and prognosing lung cancer,0,G01N
11008620,2021-05-18,Methods for treating cancer resistant to ErbB therapeutics,0,A61K|A61P|C12Q
11007503,2021-05-18,Systems and methods for a cooled nitric oxide generator,11,A61K|A61P|B01J|C01B
11001883,2021-05-11,Systems and methods for epigenetic sequencing,1,B01F|B01L|C12Q
11001870,2021-05-11,Carotenoids for treating or preventing nausea,0,A61K|A61P|C12N|C12P
11001841,2021-05-11,CCCTC-binding factor (CTCF) RNA interactome,0,C12N
10993997,2021-05-04,Methods for profiling the t cell repertoire,4,A61K|C07K|C12N|C12Q|G01N
10988765,2021-04-27,Methods and compositions for inhibiting detoxification response,0,A61K|A61P|C07K|C12N|G01N
10982291,2021-04-20,Methods of diagnosing infectious disease pathogens and their drug sensitivity,0,C12Q|G01N
10975442,2021-04-13,Molecular biomarkers for cancer immunotherapy,4,C12Q|G01N
10973860,2021-04-13,Compositions and methods for improving mitochondrial function,0,A23K|A23L|A23V|A61K|A61P|C07K|C12N|C12Y
10968216,2021-04-06,"4,5-annulated 1,2,4-triazolones",2,A61K|A61P|C07D|C12N|C12P|Y02A
10961532,2021-03-30,Methods for reactivating genes on the inactive X chromosome,1,C12N|C12Q|C12Y
10961308,2021-03-30,Embigin inhibition for promotion of hematopoietic stem and progenitor cell expansion,0,A61K|A61P|C07K|C12N
10955423,2021-03-23,Methods of estimating blood glucose and related systems,3,A61B|G01N
10954242,2021-03-23,Bicyclic urea kinase inhibitors and uses thereof,7,A61K|A61P|C07D
10953136,2021-03-23,Systems and methods of radioprotection of allografts,0,A61K|A61L
10953013,2021-03-23,Biomarkers of response to NAE inhibitors,0,A61K|A61P|C12Q|G01N|G16H|Y02A
10946377,2021-03-16,Modular instrumentation for analyzing biological fluids,1,B01L|G01N
10946073,2021-03-16,GHRH or analogues thereof for use in treatment of hepatic disease,2,A61K|A61P
10942112,2021-03-09,"Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures",2,G01B|G01J|G01N
10941393,2021-03-09,Microfluidic droplet encapsulation,0,C12N
10939989,2021-03-09,Biomimetic vascular network and devices using the same,0,A61F|G01N
10939825,2021-03-09,"Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions",0,A61B|G01B|G01N
10935556,2021-03-02,Compositions and methods for detecting and/or treating inflammation,0,A61K|A61P|C07K|G01N
10918655,2021-02-16,Stimulating platelet generation by activating mitochondrial biogenesis,0,A61K|A61N|A61P
10912604,2021-02-09,Method and apparatus for dermatological treatment and tissue reshaping,0,A61B|A61M|A61P
10908159,2021-02-02,Identification of a T cell epitope of Prevotella copri that induces T cell responses in patients with Rheumatoid arthritis,0,C07K|G01N
10906982,2021-02-02,Antagonistic anti-tumor necrosis factor receptor 2 antibodies,5,A61K|A61P|C07K
10906980,2021-02-02,Compositions and methods for non-myeloablative conditioning,0,A61K|A61P|C07K|G01N
10905780,2021-02-02,"Compounds, systems, and methods for monitoring and treating a surface of a subject",0,A61B|A61F|A61K|C07D
